BEATRICE EDWARDS to Diphosphonates
This is a "connection" page, showing publications BEATRICE EDWARDS has written about Diphosphonates.
Connection Strength
1.533
-
Acute kidney injury and bisphosphonate use in cancer: a report from the research on adverse drug events and reports (RADAR) project. J Oncol Pract. 2013 Mar; 9(2):101-6.
Score: 0.381
-
Bisphosphonates and nonhealing femoral fractures: analysis of the FDA Adverse Event Reporting System (FAERS) and international safety efforts: a systematic review from the Research on Adverse Drug Events And Reports (RADAR) project. J Bone Joint Surg Am. 2013 Feb 20; 95(4):297-307.
Score: 0.380
-
Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jaw. Lancet Oncol. 2008 Dec; 9(12):1166-72.
Score: 0.284
-
Updated recommendations for managing the care of patients receiving oral bisphosphonate therapy: an advisory statement from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2008 Dec; 139(12):1674-7.
Score: 0.284
-
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016 Jan; 31(1):16-35.
Score: 0.116
-
Osteoporosis and its implications for dental patients. J Am Dent Assoc. 2008 May; 139(5):545-52; quiz 625-6.
Score: 0.068
-
Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2011 Nov; 142(11):1243-51.
Score: 0.022